Back to Agenda
LS37: Paradigm Shift towards Electronic Package Insert -Current Status and Issues after the Revision of the Pharmaceutical Affairs Law-
Session Chair(s)
Yasuhiro Honsho
Associate Director, Safety & Risk Management Department
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Akane Kageyama
Novartis Pharma K.K., Japan
Global Drug Development Division, Regulatory Affairs Japan, RA Functions,
Shoko Sugiyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshiaki Ara
Shinshu Ueda Medical Center, Japan
Director of Pharmacy
Have an account?